Intranasal Midazolam in Children as a Pre-Operative Sedative - Part 2

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Sedation

Interventions

DRUG

Midazolam

midazolam 0.2 mg/kg given intranasally

DRUG

xylocaine

intransal xylocaine given in conjunction with intranasal midazolam

DRUG

saline placebo

intranasal saline given as placebo

Trial Locations (1)

Bassett Healthcare Network, Cooperstown

All Listed Sponsors

lead

Jennifer Victory, RN, CCRC

OTHER

NCT02356705 - Intranasal Midazolam in Children as a Pre-Operative Sedative - Part 2 | Biotech Hunter | Biotech Hunter